EUVIMEDEUVIMED entdecken
Crossref

Pulmonary microhemodynamic changes in a rabbit model of pulmonary embolism treated with cyclooxygenase-2 inhibitors

V. I. Evlakhov, T. P. Berezina, N. A. Pasatetckaia, A. I. Lopatin

Medical academic journal · 29.12.2025 · 25 (4) · 38-47

DOI: 10.17816/maj676527 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical academic journal, online erschienen am 29.12.2025. Verfasst von V. I. Evlakhov und 3 weiteren Autor:innen. Die Arbeit nennt 39 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Reducing pulmonary vascular resistance to enhance right ventricular contractility remains a significant challenge in the clinical management of pulmonary embolism. Under these conditions, the endothelium releases prostaglandin F2α and thromboxanes A2 and B2, which are involved in pulmonary vasoconstriction. Therefore, one way to influence constrictor mechanisms is to reduce their synthesis by inhibiting cyclooxygenase-2. AIM: The study aimed to evaluate pulmonary microhemodynamic changes in a rabbit model of pulmonary embolism using the selective cyclooxygenase-2 inhibitors nimesulide and celecoxib, as well as an aqueous extract of Solanum nigrum leaves. METHODS: The study was performed on isolated rabbit lungs perfused in situ under constant flow conditions. The experiment protocol included measurements of pulmonary artery perfusion pressure, capillary hydrostatic resistance, and the capillary filtration coefficient via extracorporeal blood volumetry, followed by the calculation of total pulmonary vascular, precapillary, and postcapillary resistances. RESULTS: The use of the cyclooxygenase-2 inhibitor nimesulide resulted in increased pulmonary artery pressure, capillary hydrostatic pressure, pulmonary vascular resistance, and pre- and postcapillary resistance. Celecoxib, aqueous extract of Solanum nigrum and the calcium antagonist diltiazem decreased pulmonary artery pressure, as well as pulmonary vascular and precapillary resistance. The extract of Solanum nigrum also decreased capillary hydrostatic pressure and postcapillary resistance. Following pulmonary artery embolization, the increases in pulmonary artery pressure, capillary hydrostatic pressure, and pulmonary vascular, pre-, and post-capillary resistances were significantly lower in the treated group compared to controls. The capillary filtration coefficient was inversely proportional to the capillary hydrostatic pressure. CONCLUSION: The vasodilatory effects of celecoxib and the aqueous extract of Solanum nigrum on pulmonary vessels are mediated by the inhibition of cyclooxygenase-2 and the blocking of voltage-gated Ca2+ channels in pulmonary vascular smooth muscle cells. The aqueous extract of Solanum nigrum leaves contains celecoxib and gallic acid, as well as catechin, epicatechin, and quercetin 3-O-glucuronide, which act as L-type Ca2+ channel antagonists. Cyclooxygenase-2 inhibitors reduce the permeability of the pulmonary vascular endothelium in experimental pulmonary embolism. The practical value of the study lies in its experimental confirmation that new water-soluble cyclooxygenase-2 inhibitors and calcium antagonists can be developed using Solanum nigrum components.

Zitieren

APA

Evlakhov, V. I., Berezina, T. P., Pasatetckaia, N. A., & Lopatin, A. I. (2025). Pulmonary microhemodynamic changes in a rabbit model of pulmonary embolism treated with cyclooxygenase-2 inhibitors. Medical academic journal, 25(4), 38-47. https://doi.org/10.17816/maj676527

Vancouver

Evlakhov VI, Berezina TP, Pasatetckaia NA, Lopatin AI. Pulmonary microhemodynamic changes in a rabbit model of pulmonary embolism treated with cyclooxygenase-2 inhibitors. Medical academic journal. 2025;25(4):38-47. doi:10.17816/maj676527

BibTeX
@article{Evlakhov2025,
  author = {Evlakhov, V. I. and Berezina, T. P. and Pasatetckaia, N. A. and Lopatin, A. I.},
  title = {Pulmonary microhemodynamic changes in a rabbit model of pulmonary embolism treated with cyclooxygenase-2 inhibitors},
  journal = {Medical academic journal},
  year = {2025},
  volume = {25},
  number = {4},
  pages = {38--47},
  doi = {10.17816/maj676527}
}
Kostenlos starten →